Insulin-like growth factor binding protein 5 and type-1 insulin-like growth factor receptor are differentially regulated during apoptosis in cerebellar granule cells

被引:22
|
作者
Roschier, M
Kuusisto, E
Suuronen, T
Korhonen, P
Kyrylenko, S
Salminen, A
机构
[1] Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland
[2] Inst Mol Biol & Genet, Kiev, Ukraine
[3] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland
关键词
cell culture; gene expression; insulin-like growth factor; neuronal apoptosis;
D O I
10.1046/j.1471-4159.2001.00002.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuronal apoptosis is considered to play a significant role in several neuropathological conditions. However, the molecular mechanisms underlying neuronal apoptosis are poorly understood. Insulin-like growth factor (IGF) signalling is considered to be an important regulator of neuronal differentiation, survival and apoptosis. We have examined the expression of two members of the IGF system, insulin-like growth factor binding protein 5 (IGFBP-5) and the type-1 IGF receptor (IGF1R), during apoptosis of rat cerebellar granule cells (CGCs) in vitro. We describe a prominent downregulation of IGFBP-5 mRNA and protein expression. We also show that IGF-I increases IGFBP-5 expression in CGCs and that the downregulation of IGFBP-5 mRNA can be suppressed by inhibiting mRNA synthesis with actinomycin D. The expression of IGF1R mRNA showed a transient upregulation during potassium chloride (KCl) deprivation induced apoptosis, in contrast to the IGF1R protein level, which was downregulated during KCl deprivation. Our results provide insight into the expression of IGF-related genes during neuronal apoptosis, and indicate that they mediate a protective response to the withdrawal of trophic stimulation. It seems that the expression of IGFBP-5 and IGF1R is regulated to maximize the availability of IGF and the activity of IGF-triggered survival signalling.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 50 条
  • [31] Insulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps
    Janiak, Adam
    Oset, Piotr
    Talar-Wojnarowska, Renata
    Kumor, Anna
    Malecka-Panas, Ewa
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (05): : 308 - 314
  • [32] The insulin-like growth factor binding proteins in uncultured human cartilage - Increases in insulin-like growth factor binding protein 3 during osteoarthritis
    Morales, TI
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2358 - 2367
  • [33] Relationships Between Colorectal Cancer and Insulin, Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3
    Moiseenko, A. B.
    Berstein, L. M.
    Belyaeva, A. V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S410 - S410
  • [34] MUTANTS OF HUMAN INSULIN-LIKE GROWTH FACTOR-II WITH ALTERED AFFINITIES FOR THE TYPE-1 AND TYPE-2 INSULIN-LIKE GROWTH-FACTOR RECEPTOR
    BURGISSER, DM
    ROTH, BV
    GIGER, R
    LUTHI, C
    WEIGL, S
    ZARN, J
    HUMBEL, RE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (02) : 1029 - 1033
  • [35] Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction
    Boerzsoenyi, Balazs
    Demendi, Csaba
    Nagy, Zsolt
    Toth, Katalin
    Csanad, Monika
    Pajor, Attila
    Rigo, Janos, Jr.
    Joo, Jozsef Gabor
    [J]. JOURNAL OF PERINATAL MEDICINE, 2011, 39 (06) : 701 - 707
  • [36] Prostate-specific antigen enhances bioavailability of insulin-like growth factor by degrading insulin-like growth factor binding protein 5
    Maeda, Hiroyuki
    Yonou, Hiroyuki
    Yano, Keiichi
    Ishii, Genichiro
    Saito, Seiichi
    Ochiai, Atsushi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 381 (03) : 311 - 316
  • [37] Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma
    Hoekman, K
    van Doorn, J
    Gloudemans, T
    Maassen, JA
    Schuller, AGP
    Pinedo, HM
    [J]. CLINICAL ENDOCRINOLOGY, 1999, 51 (02) : 247 - 253
  • [38] Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas
    Flood, Andrew
    Mai, Volker
    Pfeiffer, Ruth
    Kahle, Lisa
    Rosen, Clifford J.
    Lanza, Elaine
    Schatzkin, Arthur
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (06) : 1493 - 1498
  • [39] Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations
    Holmes, MD
    Pollak, MN
    Willett, WC
    Hankinson, SE
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (09) : 852 - 861
  • [40] The role of insulin-like growth factor I and insulin-like growth factor binding protein 3 in human esophageal cancer
    Sohda, M
    Kato, H
    Miyazaki, T
    Nakajima, M
    Fukuchi, M
    Manda, R
    Fukai, Y
    Masuda, N
    Kuwano, H
    [J]. ANTICANCER RESEARCH, 2004, 24 (5A) : 3029 - 3034